← All trials
NCT00448747
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2007
- Primary completion
- Jul 31, 2011
- Completion date
- Jul 31, 2011
- First posted
- Mar 19, 2007
- Last posted
- Jul 23, 2019
- Enrollment
- 101
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AEterna ZentarisLead sponsor
- Harvard UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.